Detalles de la búsqueda
1.
Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study.
Biomedicines
; 11(5)2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37239173
2.
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Semin Arthritis Rheum
; 44(4): 417-22, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25300700
3.
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
Pediatr Rheumatol Online J
; 13: 4, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25685108
Resultados
1 -
3
de 3
1
Próxima >
>>